Font Size:
a
A
A
Keyword [F-fluorodeoxyglucose]
Result: 1 - 17 | Page: 1 of 1
1.
Clinical Value Of ~(99)Tc~m-Hexakis-2Methoxy-Isobutyl Isonitrile/~(18)F-Fluorodeoxyglucose Dual Isotope Single Photon Emission Tomography
2.
The Clinical Value Of F-Fluorodeoxyglucose PET / CT And
18
F-Fluorothymidine PET / CT In The Diagnosis And Treatment Of Nasopharyngeal Carcinoma
3.
Nodal Staging, Natural Growth And Metabolic Response To Treatment Evaluated With Serial
18
F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Scans In Radical Radiotherapy Candidates With Non-small Cell Lung Cancer
4.
Clinical Application Of Positron Emission Tomography (PET) With ~(18)F-fluorodeoxyglucose In Diagnosis, Therapy And Prognosis Of Patients With Lung Cancer
5.
Clinical Application Of Positron Emission Tomography (PET) With ~(18)F-fluorodeoxyglucose (~(18)F-FDG) In Patients Of Central Nervous System Diseases
6.
11
C-Methionine PET/CT In The Evaluation Of Brain Glioma: Comparison With
18
F-Fluorodeoxyglucose PET/CT
7.
Clinical Research Of Early Predictive Value For Evaluation Response Of Breast Cancer To Neoadjuvant Chemotherapy By Using Sequence PET-CT Imaging With
18
F-fluorodeoxyglucose And The Correlation Analysis Of Ki-67 And COX-2 Expression
8.
Correlation Between Glucose Transplanter-1, Prognosis And
18
F-Fluorodeoxyglucose Uptake In Pancreatic Cancer
9.
Value Of
18
F-fluorodeoxyglucose Positron Emission Tomography-CT Imaging Combined With SCC-Ag In Serum For Diagnosis Of Early Recurrence Or Metastasis Of Cervical Squamous Carcinoma
10.
18
F-FDG PET-CT In Non-small Cell Lung Cancer: Relationship Between Primary Tumor FDG Uptake With Extensional And Metastatic Potentials
11.
Evaluation The Viability Of Alveolar Echinococcosis:A Comparison Between [
18
F]Fluorodeoxyglucose Positro N-emission Tomography And Spectral CT
12.
Prognostic Value Of
18
F-fluorodeoxyglucose PET And Inflammatory Parameters In Patients With Nasopharyngeal Carcinoma
13.
Correlation Between
18
F-Fluorodeoxyglucose Uptake And KRAS Mutation And Clinical Features In Patients With Colon Cancer
14.
Progress Of Pretreatment Metabolic Parameters From
18
F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography In Predicting The Prognosis Of Esophageal Cancer Receiving Radiotherapy
15.
18
F-Fluorodeoxyglucose Positron Emission Tomography Guide Personal Definitive Radiotherapy Dose Of Metastatic Lymph Node In Patients Of Esophageal Squamous Cell Carcinoma
16.
[
18
F]Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography In Diagnosis Of Polymyositis/Dermatomyositis
17.
Relationship Between
18
f-fluorodeoxyglucose Uptake And Response To PD-1 Inhibitor Nivalumab In Advanced Hepatocellular Carcinoma
<<First
<Prev Next>
Last>>
Jump to